Comments
Commented by Armin Schulz on March 27th, 2023 | 09:28 CEST
Barrick Gold, Globex Mining, Deutsche Bank - Banking crises fuel investments in gold
In recent weeks, two major banks, Silicon Valley Bank and Credit Suisse, have caught the attention of investors as both institutions struggle with various problems. These developments have rekindled fears of a possible banking crisis, prompting investors to seek safe havens. One of the winners of this development has been the price of gold, which has surged in recent days. So today, we look at two precious metals companies and Deutsche Bank.
Read
Commented by Nico Popp on March 27th, 2023 | 09:26 CEST
Cost pressure in the healthcare system - how you benefit: Bayer, BioNxt, BioNTech
What do you think of the German healthcare system? While doctors regularly grumble about bureaucracy and patients about long waiting times or other inconsistencies, a new divide is opening up between pharmaceutical companies. Research-based pharmaceutical companies favour long patent protection, while generics manufacturers want more lax rules. We explain the system and highlight opportunities for investors.
Read
Commented by Juliane Zielonka on March 24th, 2023 | 07:55 CET
First Phosphate, Volkswagen and Vonovia - Winners in climate poker
On March 26, the residents of Berlin will vote on whether their city should become climate neutral by 2030 - 3.6 million inhabitants travel daily by car, bus and train. For mineral explorer companies like First Phosphate, the potential acceleration in demand is already a win-win, as demand for basic materials for batteries increases dramatically. Volkswagen, for example, may soon launch large-scale industrial production of cathode materials (CAM) and precursor materials (PCAM) in Europe, thanks to the go-ahead from regulators. Vonovia is also getting enterprising: the group owns 136,000 apartments in Berlin.
Read
Commented by Juliane Zielonka on March 23rd, 2023 | 08:02 CET
BioNxt Solutions, Bayer, BioNTech - These pharma stocks offer growth potential
The risk of cancer is increasing worldwide for people over the age of 50. The reasons for this are lack of sleep and exercise, pre-existing diseases and poor nutrition. It has now also been scientifically proven that permanent stress is a cause of Parkinson's disease. According to the WHO, disabilities and deaths due to Parkinson's are increasing faster worldwide than for any other neurological disease. Pharmaceutical and biotech companies are doing everything they can to improve the quality of life of those affected. The Canadian biotech company BioNxt is working on a comparative study to improve a therapy patch for treating Parkinson's and make accompanying drug products scalable. Bayer subsidiary Bluerock Therapeutics is using data from the Apple Watch to research Parkinson's symptoms. And CEO Uğur Şahin of BioNTech has closed a billion-dollar deal in cancer therapy.
Read
Commented by Fabian Lorenz on March 23rd, 2023 | 08:00 CET
Gold to USD 3,000? Barrick Gold and Desert Gold profit. What is going on at Vonovia?
Will the price of gold rise to USD 3,000 per ounce before the end of the year? That is what investment professional Leigh Goehring thinks is possible. He is a managing director at Goehring & Rozencwajg, manages a commodity fund, among other things, and expects a "decade of inflation." If the forecast comes true, gold stocks will at least be an attractive portfolio addition. In addition to industry heavyweights like Barrick Gold, explorers can be worthwhile as leverage to the gold price. One such explorer is Desert Gold. The share of the Canadian company reacted yesterday with a price jump of over 10% to a project update. In contrast, the outlook for "concrete gold" remains challenging. Vonovia, for example, was once again downgraded by analysts despite the significant share price losses of recent months. At the same time, there are also positive comments.
Read
Commented by Armin Schulz on March 23rd, 2023 | 07:58 CET
Manuka Resources starts gold production. Can Varta and K+S manage the turnaround?
On March 22, all eyes were on the FED decision. Will the balancing act between fighting inflation and stabilizing the banking system succeed? The collapse of Silicon Valley Bank and the difficulties of Credit Suisse have caused plenty of uncertainty. The result has been significant premiums in the price of gold and cryptocurrencies as people try to protect their money. But regardless of the interest rate decision, there is interesting news on companies that have been under pressure recently and are waiting for a turnaround. We take a look at three of those candidates today.
Read
Commented by Stefan Feulner on March 23rd, 2023 | 07:54 CET
RWE, Myriad Uranium, Cameco - The best environment ever
The geopolitical events of 2022 have heightened concerns about the security of supply and, combined with the ongoing focus on climate change, have created transformative tailwinds for the nuclear power industry. While Germany's last three nuclear reactors face shutdown, major industrialized nations are relying on zero-carbon nuclear power. As a result, the uranium price should be poised for a brilliant comeback after a bear market that has lasted for years.
Read
Commented by André Will-Laudien on March 22nd, 2023 | 10:49 CET
A new banking crisis in 2023? Deutsche Bank, Blackrock Silver, Commerzbank - Gold and Silver are back!
Central bankers are currently in a huge dilemma. They should fight the price pressure with a tough interest rate policy and gradual withdrawal of liquidity. However, this increases the existing risk of recession and the danger of a new financial crisis worldwide. In fact, past interest rate restrictions have already left grinding marks in the US banking system because gigantic write-downs on price losses still lie dormant in the books of institutions that had believed in eternally low interest rates. After the collapse of Silicon Valley Bank and the forced takeover of Credit Suisse, uncertainty has again taken a stranglehold on the markets. Gold and silver reacted with a giant leap. We look at the current situation.
Read
Commented by Nico Popp on March 22nd, 2023 | 10:42 CET
Subsidies beckon, shareholders profit: Volkswagen, NEL, First Hydrogen
Money from the state comes in handy for many companies. This is especially true when the challenges are great, and the capital requirements are immense. For large industrial companies, subsidies have always been part of the package. Just recently, Volkswagen, for example, picked up money in South Carolina. We explain in which industries there is also something "to be had" for shareholders.
Read
Commented by Fabian Lorenz on March 22nd, 2023 | 09:45 CET
Buffett adds to oil stocks: Shell, Saturn Oil + Gas, BYD
Star investor Warren Buffett has long been a fan of oil stocks. So it is no surprise that he is taking advantage of the current weak oil price to add to his favourite stock (after Apple): Occidental Petroleum. Berkshire Hathaway now holds around 23% of the US oil producer. Those looking to take advantage of the low oil price opportunity should also look at Shell and Saturn Oil & Gas. Numerous analysts recommend Shell and Saturn Oil & Gas is on its way to becoming a well-known producer after several spectacular takeovers. There is also news on BYD. Also a favourite of Buffett, but it is currently in a difficult market environment. Here is what recent media reports suggest.
Read